Non-Disseminated Breast Cancer: Controversial Issues in Management
In the last two decades, there has been a major increase in the actual numbers of women diagnosed with breast cancer (from 65000 new cases 20 years ago in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1993
|
Schriftenreihe: | Radiation Oncology
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | In the last two decades, there has been a major increase in the actual numbers of women diagnosed with breast cancer (from 65000 new cases 20 years ago in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-stage disease in 1992). These changes are clearly related to the woman's greater sensitivity to abnormalities in the breast and her seeking medical care, to the physician's greater awareness of the potential diagnosis of cancer, and to the major and important impact of mammographic screening. These changes have had a major impact on the questions of appropriate treatment, thereby contributing to the controversies in the disease. What is the role of surgery? What are the respective advantages of radical mastectomy, modified radical mastectomy, and conservation surgery with and without supplementary treatment? What is the role of radiation therapy? When should radiation therapy be performed after mastectomy, and what volumes should be irradiated post mastectomy? Where is radiation therapy indicated after conservation surgery, and when is radiation therapy an effective palliative treatment measure? When should chemotherapy and/or hormonal therapy be used as an adjuvant to primary treatment and when as an effective palliative treatment? This book by Levitt and Fletcher addresses these critical and important issues |
Beschreibung: | 1 Online-Ressource (XIV, 168 p. 5 illus) |
ISBN: | 9783642845932 |
DOI: | 10.1007/978-3-642-84593-2 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046145181 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1993 |||| o||u| ||||||eng d | ||
020 | |a 9783642845932 |9 978-3-642-84593-2 | ||
024 | 7 | |a 10.1007/978-3-642-84593-2 |2 doi | |
035 | |a (ZDB-2-SME)978-3-642-84593-2 | ||
035 | |a (OCoLC)1119013963 | ||
035 | |a (DE-599)BVBBV046145181 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 615.842 |2 23 | |
084 | |a XH 8450 |0 (DE-625)152958:13129 |2 rvk | ||
245 | 1 | 0 | |a Non-Disseminated Breast Cancer |b Controversial Issues in Management |c edited by Gilbert H. Fletcher, Seymour H. Levitt |
264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1993 | |
300 | |a 1 Online-Ressource (XIV, 168 p. 5 illus) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Radiation Oncology | |
520 | |a In the last two decades, there has been a major increase in the actual numbers of women diagnosed with breast cancer (from 65000 new cases 20 years ago in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-stage disease in 1992). These changes are clearly related to the woman's greater sensitivity to abnormalities in the breast and her seeking medical care, to the physician's greater awareness of the potential diagnosis of cancer, and to the major and important impact of mammographic screening. These changes have had a major impact on the questions of appropriate treatment, thereby contributing to the controversies in the disease. What is the role of surgery? What are the respective advantages of radical mastectomy, modified radical mastectomy, and conservation surgery with and without supplementary treatment? What is the role of radiation therapy? When should radiation therapy be performed after mastectomy, and what volumes should be irradiated post mastectomy? Where is radiation therapy indicated after conservation surgery, and when is radiation therapy an effective palliative treatment measure? When should chemotherapy and/or hormonal therapy be used as an adjuvant to primary treatment and when as an effective palliative treatment? This book by Levitt and Fletcher addresses these critical and important issues | ||
650 | 4 | |a Radiotherapy | |
650 | 4 | |a Radiotherapy | |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Fletcher, Gilbert H. |4 edt | |
700 | 1 | |a Levitt, Seymour H. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642845956 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540545149 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642845949 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-84593-2 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031525366 | ||
966 | e | |u https://doi.org/10.1007/978-3-642-84593-2 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180481531445248 |
---|---|
any_adam_object | |
author2 | Fletcher, Gilbert H. Levitt, Seymour H. |
author2_role | edt edt |
author2_variant | g h f gh ghf s h l sh shl |
author_facet | Fletcher, Gilbert H. Levitt, Seymour H. |
building | Verbundindex |
bvnumber | BV046145181 |
classification_rvk | XH 8450 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-642-84593-2 (OCoLC)1119013963 (DE-599)BVBBV046145181 |
dewey-full | 615.842 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.842 |
dewey-search | 615.842 |
dewey-sort | 3615.842 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-3-642-84593-2 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03500nmm a2200517zc 4500</leader><controlfield tag="001">BV046145181</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1993 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642845932</subfield><subfield code="9">978-3-642-84593-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-84593-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-84593-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119013963</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145181</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.842</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8450</subfield><subfield code="0">(DE-625)152958:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Non-Disseminated Breast Cancer</subfield><subfield code="b">Controversial Issues in Management</subfield><subfield code="c">edited by Gilbert H. Fletcher, Seymour H. Levitt</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 168 p. 5 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Radiation Oncology</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In the last two decades, there has been a major increase in the actual numbers of women diagnosed with breast cancer (from 65000 new cases 20 years ago in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-stage disease in 1992). These changes are clearly related to the woman's greater sensitivity to abnormalities in the breast and her seeking medical care, to the physician's greater awareness of the potential diagnosis of cancer, and to the major and important impact of mammographic screening. These changes have had a major impact on the questions of appropriate treatment, thereby contributing to the controversies in the disease. What is the role of surgery? What are the respective advantages of radical mastectomy, modified radical mastectomy, and conservation surgery with and without supplementary treatment? What is the role of radiation therapy? When should radiation therapy be performed after mastectomy, and what volumes should be irradiated post mastectomy? Where is radiation therapy indicated after conservation surgery, and when is radiation therapy an effective palliative treatment measure? When should chemotherapy and/or hormonal therapy be used as an adjuvant to primary treatment and when as an effective palliative treatment? This book by Levitt and Fletcher addresses these critical and important issues</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiotherapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fletcher, Gilbert H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levitt, Seymour H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642845956</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540545149</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642845949</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-84593-2</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525366</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-84593-2</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV046145181 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:27Z |
institution | BVB |
isbn | 9783642845932 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525366 |
oclc_num | 1119013963 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XIV, 168 p. 5 illus) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1993 |
publishDateSearch | 1993 |
publishDateSort | 1993 |
publisher | Springer Berlin Heidelberg |
record_format | marc |
series2 | Radiation Oncology |
spelling | Non-Disseminated Breast Cancer Controversial Issues in Management edited by Gilbert H. Fletcher, Seymour H. Levitt Berlin, Heidelberg Springer Berlin Heidelberg 1993 1 Online-Ressource (XIV, 168 p. 5 illus) txt rdacontent c rdamedia cr rdacarrier Radiation Oncology In the last two decades, there has been a major increase in the actual numbers of women diagnosed with breast cancer (from 65000 new cases 20 years ago in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-stage disease in 1992). These changes are clearly related to the woman's greater sensitivity to abnormalities in the breast and her seeking medical care, to the physician's greater awareness of the potential diagnosis of cancer, and to the major and important impact of mammographic screening. These changes have had a major impact on the questions of appropriate treatment, thereby contributing to the controversies in the disease. What is the role of surgery? What are the respective advantages of radical mastectomy, modified radical mastectomy, and conservation surgery with and without supplementary treatment? What is the role of radiation therapy? When should radiation therapy be performed after mastectomy, and what volumes should be irradiated post mastectomy? Where is radiation therapy indicated after conservation surgery, and when is radiation therapy an effective palliative treatment measure? When should chemotherapy and/or hormonal therapy be used as an adjuvant to primary treatment and when as an effective palliative treatment? This book by Levitt and Fletcher addresses these critical and important issues Radiotherapy Therapie (DE-588)4059798-2 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Brustkrebs (DE-588)4008528-4 s Therapie (DE-588)4059798-2 s DE-604 Fletcher, Gilbert H. edt Levitt, Seymour H. edt Erscheint auch als Druck-Ausgabe 9783642845956 Erscheint auch als Druck-Ausgabe 9783540545149 Erscheint auch als Druck-Ausgabe 9783642845949 https://doi.org/10.1007/978-3-642-84593-2 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Non-Disseminated Breast Cancer Controversial Issues in Management Radiotherapy Therapie (DE-588)4059798-2 gnd Brustkrebs (DE-588)4008528-4 gnd |
subject_GND | (DE-588)4059798-2 (DE-588)4008528-4 (DE-588)4143413-4 |
title | Non-Disseminated Breast Cancer Controversial Issues in Management |
title_auth | Non-Disseminated Breast Cancer Controversial Issues in Management |
title_exact_search | Non-Disseminated Breast Cancer Controversial Issues in Management |
title_full | Non-Disseminated Breast Cancer Controversial Issues in Management edited by Gilbert H. Fletcher, Seymour H. Levitt |
title_fullStr | Non-Disseminated Breast Cancer Controversial Issues in Management edited by Gilbert H. Fletcher, Seymour H. Levitt |
title_full_unstemmed | Non-Disseminated Breast Cancer Controversial Issues in Management edited by Gilbert H. Fletcher, Seymour H. Levitt |
title_short | Non-Disseminated Breast Cancer |
title_sort | non disseminated breast cancer controversial issues in management |
title_sub | Controversial Issues in Management |
topic | Radiotherapy Therapie (DE-588)4059798-2 gnd Brustkrebs (DE-588)4008528-4 gnd |
topic_facet | Radiotherapy Therapie Brustkrebs Aufsatzsammlung |
url | https://doi.org/10.1007/978-3-642-84593-2 |
work_keys_str_mv | AT fletchergilberth nondisseminatedbreastcancercontroversialissuesinmanagement AT levittseymourh nondisseminatedbreastcancercontroversialissuesinmanagement |